中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
10期
42-42,43
,共2页
脑梗死%血塞通注射液%有效性%安全性
腦梗死%血塞通註射液%有效性%安全性
뇌경사%혈새통주사액%유효성%안전성
Cerebral infarction%Xuesaitong injection%Effectiveness%Safety
目的：探讨血塞通注射液对脑梗死患者的临床疗效及安全性，探讨其临床价值。方法95例急性脑梗死按照随机分组的方法分为治疗组（n=50）和对照组（n=45），治疗组患者用血塞通注射液静滴，对照组患者给予丹参注射液静滴，对比两组的疗效及不良反应发生率。结果对照组治疗总有效率低于治疗组（P＜0.05），对照组的日常生活活动能力评分显著低于治疗组（P＜0.05），两组的不良反应发生率无显著性差异（P＞0.05）。结论血塞通注射液治疗脑梗死有显著的疗效，无严重不良反应发生，值得推广。
目的：探討血塞通註射液對腦梗死患者的臨床療效及安全性，探討其臨床價值。方法95例急性腦梗死按照隨機分組的方法分為治療組（n=50）和對照組（n=45），治療組患者用血塞通註射液靜滴，對照組患者給予丹參註射液靜滴，對比兩組的療效及不良反應髮生率。結果對照組治療總有效率低于治療組（P＜0.05），對照組的日常生活活動能力評分顯著低于治療組（P＜0.05），兩組的不良反應髮生率無顯著性差異（P＞0.05）。結論血塞通註射液治療腦梗死有顯著的療效，無嚴重不良反應髮生，值得推廣。
목적：탐토혈새통주사액대뇌경사환자적림상료효급안전성，탐토기림상개치。방법95례급성뇌경사안조수궤분조적방법분위치료조（n=50）화대조조（n=45），치료조환자용혈새통주사액정적，대조조환자급여단삼주사액정적，대비량조적료효급불량반응발생솔。결과대조조치료총유효솔저우치료조（P＜0.05），대조조적일상생활활동능력평분현저저우치료조（P＜0.05），량조적불량반응발생솔무현저성차이（P＞0.05）。결론혈새통주사액치료뇌경사유현저적료효，무엄중불량반응발생，치득추엄。
Objective To analyze the clinical effects and safety of Xuesaitong injection in the treatment of cerebral infarction. Methods 95 cases of cerebral infarction were divided into the treatment group (n=50) and the control group (n=45). The control group took salvia miltiorrhiza injection and the treatment group took Xuesaitong injection. The curative effects and adverse reaction rate were measured then. Result The total effective rate of the control group was significant lower than that of the treatment group (P<0.05). The activities of daily living score of the control group was significant lower than that of the treatment group (P<0.05). There has no significant different in the adverse reaction rate between the two groups(P>0.05). Conclusion Xuesaitong injection has great contribution in treating cerebral infarction.
